OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 220 citing articles:

Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19
D. Clark Files, Frank Tacke, Alexandra O’Sullivan, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010547-e1010547
Open Access | Times Cited: 25

COVID-19 patients share common, corticosteroid-independent features of impaired host immunity to pathogenic molds
Beeke Tappe, Chris D. Lauruschkat, Lea Strobel, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25

Immunomodulatory effects of zinc and its impact on COVID-19 severity
Manish Dhawan, Talha Bin Emran, Priyanaka, et al.
Annals of Medicine and Surgery (2022) Vol. 77
Open Access | Times Cited: 24

MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review
Jivan Qasim Ahmed, Sazan Qadir Maulud, Manish Dhawan, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 7, pp. 788-799
Open Access | Times Cited: 24

Immunomodulatory and therapeutic implications of vitamin D in the management of COVID-19
Manish Dhawan, Priyanka Choudhary, Om Prakash Choudhary
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 23

Microglial Inflammatory Responses to SARS‐CoV‐2 Infection: A Comprehensive Review
Rajen Dey, Biswadev Bishayi
Cellular and Molecular Neurobiology (2023) Vol. 44, Iss. 1
Closed Access | Times Cited: 14

CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infection
Ilaria Ferrigno, Laura Verzellesi, Marta Ottone, et al.
Inflammation Research (2024) Vol. 73, Iss. 4, pp. 515-530
Closed Access | Times Cited: 5

Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection
Bryce M. Warner, Robert Vendramelli, Amrit S. Boese, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316952-e0316952
Open Access

Role of toll-like receptors in post-COVID-19 associated neurodegenerative disorders?
Senthil Kumaran Satyanarayanan, Tsz Fung Yip, Zixu Han, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access

Efficient and scalable construction of clinical variable networks for complex diseases with RAMEN
Yiwei Xiong, Jingtao Wang, Xiaoxiao Shang, et al.
Cell Reports Methods (2025), pp. 101022-101022
Open Access

Autoinflammatory Diseases and Cytokine Storms—Imbalances of Innate and Adaptative Immunity
Annalisa Marcuzzi, E. Melloni, Giorgio Zauli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11241-11241
Open Access | Times Cited: 31

Calcium, Magnesium, and Zinc Supplementation during Pregnancy: The Additive Value of Micronutrients on Maternal Immune Response after SARS-CoV-2 Infection
Ioana Mihaela Citu, Cosmin Cîtu, Mădălin-Marius Margan, et al.
Nutrients (2022) Vol. 14, Iss. 7, pp. 1445-1445
Open Access | Times Cited: 22

Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections
Ebba Rosendal, Ionut Sebastian Mihai, Miriam Becker, et al.
mBio (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 22

The Efficacy of Traditional Medicinal Plants in Modulating the Main Protease of SARS‐CoV‐2 and Cytokine Storm
Jomin Choe, Phaik Har Yong, Zhi Xiang Ng
Chemistry & Biodiversity (2022) Vol. 19, Iss. 11
Open Access | Times Cited: 19

Neurological damages in COVID‐19 patients: Mechanisms and preventive interventions
Sibani Sarkar, Subhajit Karmakar, Malini Basu, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 12

SARS-CoV-2 ORF8 accessory protein is a virulence factor
Melissa Belló-Pérez, Jesús Hurtado-Tamayo, Anna Z. Mykytyn, et al.
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 12

In-silico study for the identification of potential destabilizers between the spike protein of SARS-CoV-2 and human ACE-2
Jeffry Medina-Barandica, Neyder Contreras‐Puentes, Arnulfo Tarón-Dunoyer, et al.
Informatics in Medicine Unlocked (2023) Vol. 40, pp. 101278-101278
Open Access | Times Cited: 11

Effect of polyphenols against complications of COVID-19: current evidence and potential efficacy
Mahdi Vajdi, Arash Karimi, Shirin Hassanizadeh, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 2, pp. 307-327
Closed Access | Times Cited: 4

14th National Congress of the Portuguese Society of Clinical Chemistry, Genetics and Laboratory Medicine

Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 6, pp. eA43-eA129
Open Access | Times Cited: 4

Targeting ATP2B1 impairs PI3K/Akt/FOXO signaling and reduces SARS-COV-2 infection and replication
Pasqualino de Antonellis, Veronica Ferrucci, Marco Miceli, et al.
EMBO Reports (2024) Vol. 25, Iss. 7, pp. 2974-3007
Open Access | Times Cited: 4

Scroll to top